World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
48910
World Ranking
5730
National Ranking
3081

Research.com Recognitions

  • 1977 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Peter H. Wiernik is affiliated with the Cancer Research Foundation of New York in the United States. Their research primarily focuses on medicine, with a concentration in hematology, public health, environmental and occupational health, oncology, genetics, and pulmonary and respiratory medicine.

The main topics covered in their work include:

  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Retinoids in leukemia and cellular processes
  • Childhood Cancer Survivors' Quality of Life
  • Lung Cancer Diagnosis and Treatment

Recent significant papers authored or co-authored by Peter H. Wiernik include:

  • Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL, 2021, Blood
  • The importance of low-dose CT screening to identify emphysema in asymptomatic participants with and without a prior diagnosis of COPD, 2021, Clinical Imaging
  • CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials, 2021, Blood Advances
  • Long-Term Progression-Free Survival of Patients with Metastatic Melanoma or Renal Cell Carcinoma following High-Dose Interleukin-2, 2021, Journal of Investigative Medicine
  • The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era, 2020, Biology of Blood and Marrow Transplantation

Frequent co-authors include:

  • Hillard M. Lazarus
  • Mark R. Litzow
  • Martin S. Tallman
  • David I. Marks
  • Elisabeth Paietta

Publications by Peter H. Wiernik appear most often in the following venues:

  • Journal of Investigative Medicine
  • UNC Libraries
  • British Journal of Haematology
  • Blood
  • Bone Marrow Transplantation

Peter H. Wiernik received the Fellow of the American Association for the Advancement of Science (AAAS) award in 1977.

Best Publications

  • Hypersensitivity reactions from taxol.

    R B Weiss;R C Donehower;P H Wiernik;T Ohnuma

  • All-trans-Retinoic Acid in Acute Promyelocytic Leukemia

    Martin S. Tallman;Janet W. Andersen;Charles A. Schiffer;Frederick R. Appelbaum

  • In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

    Anthony H. Goldstone;Susan M. Richards;Hilliard M. Lazarus;Martin S. Tallman

  • Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993

    Jacob M. Rowe;Georgina Buck;Alan Kenneth Burnett;Raj Chopra

  • Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission

    Peter A. Cassileth;David P. Harrington;Frederick R. Appelbaum;Hillard M. Lazarus

  • Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

    Stephen C. Schimpff;Viola Mae Young;William H. Greene;Gerald D. Vermeulen

  • Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

    Anthony V. Moorman;Christine J. Harrison;Georgina A.N. Buck;Sue M. Richards

  • Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study

    J Yates;O Glidewell;P Wiernik;Cooper

  • Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia

    Peter H. Wiernik;Phillip L.C. Banks;Delvyn C. Case;Zalmen A. Arlin

  • Phase I clinical and pharmacokinetic study of taxol

    Peter H. Wiernik;Edward L. Schwartz;Janice J. Strauman;Janice P. Dutcher

  • Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B.

    KR Rai;JF Holland;OJ Glidewell;V Weinberg

  • Neurotoxicity of Commonly Used Antineoplastic Agents

    Howard D. Weiss;Michael D. Walker;Peter H. Wiernik

  • Staphylococcus epidermidis: An Increasing Cause of Infection in Patients with Granulocytopenia

    James C. Wade;Stephen C. Schimpff;Kathryn A. Newman;Peter H. Wiernik

  • Treatment of Invasive Aspergillosis: Relation of Early Diagnosis and Treatment to Response

    Joseph Aisner;Stephen C. Schimpff;Peter H. Wiernik

  • Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high‐dosage schedule

    Robert S. Benjamin;Peter H. Wiernik;Nicholas R. Bachur

  • Clinical presentation of infection in granulocytopenic patients.

    Edward A. Sickles;William H. Greene;Peter H. Wiernik

  • Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma

    Peter H. Wiernik;Izidore S. Lossos;Joseph M. Tuscano;Glen Justice

  • Metastatic Renal Cancer Treated with Interleukin-2 and Lymphokine-Activated Killer Cells: A Phase II Clinical Trial

    Fisher Ri;Coltman Ca;Doroshow Jh;Rayner Aa

  • High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.

    Kathryn G. Roberts;Zhaohui Gu;Debbie Payne-Turner;Kelly McCastlain

  • Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis.

    Schimpff Sc;Greene Wh;Young Vm;Fortner Cl

Frequent Co-Authors

Martin S. Tallman
Martin S. Tallman Northwestern University
Jacob M. Rowe
Jacob M. Rowe Technion – Israel Institute of Technology
Joseph A. Sparano
Joseph A. Sparano Albert Einstein College of Medicine
Hillard M. Lazarus
Hillard M. Lazarus Case Western Reserve University
John M. Bennett
John M. Bennett University of Rochester Medical Center
Charles A. Schiffer
Charles A. Schiffer Wayne State University
Mark R. Litzow
Mark R. Litzow Mayo Clinic
Gordon W. Dewald
Gordon W. Dewald Mayo Clinic
Clara D. Bloomfield
Clara D. Bloomfield The Ohio State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine can open up a range of educational and professional options beyond the traditional MD route. Many students today are exploring degrees that offer flexibility and specialized skills, especially through online programs.

For those interested in healthcare administration, there are cheapest mha programs online that provide the management expertise needed in hospitals and clinics. If you wish to advance your nursing credentials, several msn to dnp programs online are available, allowing nurses to step into leadership or advanced practice roles.

Future pharmacists can benefit from pharmacy school online accredited programs. These accredited online degrees make it possible to pursue a doctorate in pharmacy while maintaining work or personal commitments.

Additionally, the rapidly growing field of health informatics is accessible through health information technology programs online. This pathway is ideal for those who want to blend healthcare with information systems and data management.

Choosing these alternate healthcare degrees online can lead to rewarding careers in a dynamic healthcare landscape.

Best Scientists Citing Peter H. Wiernik

Trending Scientists

Recently Published Articles